ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?

Park, Eun Jung; Hwang, Sung-Joo; Baik, Seung Hyuk

Park, Eun Jung; Hwang, Sung-Joo; Baik, Seung Hyuk.

Afiliação

Park EJ; Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Hwang SJ; Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Korea.
Baik SH; College of Pharmacy, Yonsei University, Incheon, Korea.

Ann Surg Oncol ; 29(13): 8593-8594, 2022 12.

Article em En | MEDLINE | ID: mdl-36001184

Assuntos

Hipertermia Induzida; Quimioterapia Intraperitoneal Hipertérmica; Humanos; Oxaliplatina; Procedimentos Cirúrgicos de Citorredução; Glucose

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioterapia Intraperitoneal Hipertérmica / Hipertermia Induzida Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google